BioXcel Therapeutics Reports Third Quarter 2025 Financial Results and Provides Update on Late-Stage Clinical Programs for Agitation in Bipolar, Schizophrenia, and …

NDA submission expected in early Q1 2026 for expanded usage of IGALMI® in home setting based on positive data from the ...
Penn Live

Doctor sees new hope for Alzheimer’s disease patients and families. Here’s why

The combination of a recently approved blood test for the detection of Alzheimer’s disease, combined with two medications that slow the progression of the disease, is drastically improving outcomes ...
Hosted on MSN

The Stages Of Alzheimer’s Disease — And How Families Can Prepare

Alzheimer's disease is a kind of brain disease that progressively impairs thinking, behaviour, and memory. It is most prevalent in older adults, and people find it more difficult to carry out daily ...